1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Oncolytic Virus Therapy Market
2.3. Global Oncolytic Virus Therapy Market, By Virus Type, 2025 (US$ Million)
2.4. Global Oncolytic Virus Therapy Market, By Application, 2025 (US$ Million)
2.5. Global Oncolytic Virus Therapy Market, By End Use, 2025 (US$ Million)
2.6. Global Oncolytic Virus Therapy Market, By Geography, 2025 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2025

3. Oncolytic Virus Therapy Market: Competitive Analysis
3.1. Market Positioning of Key Oncolytic Virus Therapy Market Vendors
3.2. Strategies Adopted by Oncolytic Virus Therapy Market Vendors

4. Oncolytic Virus Therapy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Oncolytic Virus Therapy Market Value, 2024 - 2034, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. Porter's Five Force Model
4.5.1. Supplier Power
4.5.2. Buyer Power
4.5.3. Threat Of Substitutes
4.5.4. Threat Of New Entrants
4.5.5. Competitive Rivalry
4.6. PESTEL Analysis
4.6.1. Political Landscape
4.6.2. Economic Landscape
4.6.3. Social Landscape
4.6.4. Technology Landscape
4.6.5. Environmental Landscape
4.6.6. Legal Landscape

5. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2025 Versus 2034
5.3. Market Segmentation
5.3.1. Genetically Engineered Oncolytic Viruses
5.3.1.1. Herpes Simplex Virus
5.3.1.2. Adenovirus
5.3.1.3. Vaccinia Virus
5.3.2. Oncolytic Wild-type Viruses
5.3.2.1. Reovirus
5.3.2.2. Newcastle Disease Virus
5.3.2.3. Vesicular Stomatitis Virus

6. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2025 Versus 2034
6.3. Market Segmentation
6.3.1. Solid Tumor
6.3.1.1. Breast Cancer
6.3.1.2. Prostate Cancer
6.3.1.3. Lung Cancer
6.3.1.4. Glioblastoma
6.3.2. Melanoma
6.3.2.1. Hematological Malignancies
6.3.2.2. Lymphoma
6.3.2.3. Leukemia
6.3.2.4. Myeloma

7. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2025 Versus 2034
7.3. Market Segmentation
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Cancer Research Institutes

8. North America Oncolytic Virus Therapy Market, 2024-2034, USD (Million)
8.1. Market Overview
8.2. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
8.3. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
8.4. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
8.5. Oncolytic Virus Therapy Market: By Region, 2024-2034, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
8.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
8.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
8.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
8.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
8.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
8.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)

9. UK and European Union Oncolytic Virus Therapy Market, 2024-2034, USD (Million)
9.1. Market Overview
9.2. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.3. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.4. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
9.5. Oncolytic Virus Therapy Market: By Region, 2024-2034, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.5.1.4.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.5.1.4.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
9.5.1.5. France
9.5.1.5.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.5.1.5.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.5.1.5.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
9.5.1.6.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
9.5.1.6.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)

10. Asia Pacific Oncolytic Virus Therapy Market, 2024-2034, USD (Million)
10.1. Market Overview
10.2. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.3. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.4. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
10.5. Oncolytic Virus Therapy Market: By Region, 2024-2034, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
10.5.1.3. India
10.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.5.1.4.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.5.1.4.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.5.1.5.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.5.1.5.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
10.5.1.6.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
10.5.1.6.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)

11. Latin America Oncolytic Virus Therapy Market, 2024-2034, USD (Million)
11.1. Market Overview
11.2. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
11.3. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
11.4. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
11.5. Oncolytic Virus Therapy Market: By Region, 2024-2034, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
11.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
11.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
11.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
11.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
11.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
11.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)

12. Middle East and Africa Oncolytic Virus Therapy Market, 2024-2034, USD (Million)
12.1. Market Overview
12.2. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
12.3. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
12.4. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
12.5. Oncolytic Virus Therapy Market: By Region, 2024-2034, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
12.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
12.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
12.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
12.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2024-2034, USD (Million)
12.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2024-2034, USD (Million)
12.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2024-2034, USD (Million)

13. Company Profile
13.1. Amgen (Company Overview, Financial Performance, Product Portfolio, Strategic Initiatives)
13.2. Genelux Corporation
13.3. Oncolytics Biotech
13.4. Sorrento Therapeutics
13.5. Transgene SA
13.6. Daiichi Sankyo Company
13.7. Shanghai Sunway Biotech Co Ltd
13.8. Takara Bio Inc.
13.9. PsiOxus Therapeutics
13.10. SillaJen Inc.
13.11. ViroCure
13.12. Other Notable Players